TBIO vs TNGX
Loading...
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TBIO is a Sell and TNGX is a Sell.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
TBIO’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 0 green FA rating(s).
- TBIO’s FA Score: 0 green, 5 red.
- TNGX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
TBIO’s TA Score shows that 5 TA indicator(s) are bullish while TNGX’s TA Score has 3 bullish TA indicator(s).
- TBIO’s TA Score: 5 bullish, 5 bearish.
- TNGX’s TA Score: 3 bullish, 4 bearish.
Price Growth
TBIO (@Medical Specialties) experienced а -12.11% price change this week, while TNGX (@Biotechnology) price change was +5.84% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +2.34%. For the same industry, the average monthly price growth was +4.51%, and the average quarterly price growth was +16.96%.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.
Reported Earning Dates
TBIO is expected to report earnings on Aug 06, 2024.
TNGX is expected to report earnings on Aug 06, 2024.
Industries' Descriptions
@Medical Specialties (+2.34% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Biotechnology (+1.41% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| TBIO | TNGX | TBIO / TNGX | |
| Capitalization | 12.9M | 803M | 2% |
| EBITDA | -32.79M | N/A | - |
| Gain YTD | 1027.820 | -24.040 | -4,275% |
| P/E Ratio | 64.52 | N/A | - |
| Revenue | 30M | N/A | - |
| Total Cash | 41.5M | N/A | - |
| Total Debt | 49.9M | N/A | - |
| TBIO | TNGX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | N/A |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 75% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 74% |
| MACD ODDS (%) | 11 days ago 78% | N/A |
| TrendWeek ODDS (%) | 2 days ago 88% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 87% | 2 days ago 79% |
| Advances ODDS (%) | 4 days ago 83% | 4 days ago 84% |
| Declines ODDS (%) | 6 days ago 88% | 2 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 84% | 2 days ago 83% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 84% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TRCVX | 25.61 | 0.07 | +0.27% |
| Nuveen Large Cap Value Idx Retire | |||
| AVUSX | 17.20 | 0.04 | +0.23% |
| Avantis® U.S. Equity Institutional | |||
| MBVKX | 20.31 | 0.03 | +0.15% |
| BlackRock Large Cap Focus Value K | |||
| QKBGX | 21.88 | 0.03 | +0.14% |
| Federated Hermes MDT Balanced R6 | |||
| FEMAX | 10.96 | N/A | N/A |
| First Eagle U.S. SMID Cap Opportunity A | |||
TBIO and
Correlation & Price change
A.I.dvisor indicates that over the last year, TBIO has been loosely correlated with EMBC. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TBIO jumps, then EMBC could also see price increases.
| Ticker / NAME | Correlation To TBIO | 1D Price Change % | ||
|---|---|---|---|---|
| TBIO | 100% | +3.45% | ||
| EMBC - TBIO | 56% Loosely correlated | +1.76% | ||
| ADCT - TBIO | 36% Loosely correlated | +0.24% | ||
| STE - TBIO | 34% Loosely correlated | +0.85% | ||
| BFLY - TBIO | 30% Poorly correlated | +1.98% | ||
| TNGX - TBIO | 29% Poorly correlated | -3.47% | ||
More | ||||
TNGX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.
| Ticker / NAME | Correlation To TNGX | 1D Price Change % | ||
|---|---|---|---|---|
| TNGX | 100% | -3.47% | ||
| AXON - TNGX | 41% Loosely correlated | -0.57% | ||
| PSTX - TNGX | 40% Loosely correlated | -4.63% | ||
| MDGL - TNGX | 39% Loosely correlated | +1.33% | ||
| IDYA - TNGX | 36% Loosely correlated | -2.48% | ||
| ORMP - TNGX | 36% Loosely correlated | -1.29% | ||
More | ||||